Figure 8. Glycemic control in MMP failing–to-respond DM population vs KPNW DM total population (non-MMP). The MMP initiated care to improve glycemic control in patients on priority drug therapies in 1998. A six-month sample (6/1/98 – 12/31/98) of all MMP diabetes patients and of non-MMP patients who were on the diabetes registry but not managed by MMP were identified (MMP = 4%, non-MMP = 96%). Baseline A1c (A1c obtained up to 60 days prior to 6/1/98) was compared to last A1c (A1c obtained up to 14 months after baseline). Where the last A1c was not available, last A1c was considered to have not changed from baseline A1c. More MMP patients achieved goal of A1c 8 mg/dL than non-MMP patients (59.3% for MMP and 41.3% for non-MMP patients). The mean improvement in A1c was higher for MMP patients than non-MMP (decrease 0.84 vs 0.63 in non-MMP).